BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sakamoto Y, Shimada K, Nara S, Esaki M, Ojima H, Sano T, Yamamoto J, Kosuge T. Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients. J Gastrointest Surg. 2010;14:335-343. [PMID: 19902311 DOI: 10.1007/s11605-009-1072-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 D'Souza MA, Al-Saffar HA, Fernández Moro C, Shtembari S, Danielsson O, Sparrelid E, Sturesson C. Redefining resection margins and dissection planes in perihilar cholangiocarcinoma-radical resection is a rare event. Virchows Arch 2021. [PMID: 34783866 DOI: 10.1007/s00428-021-03231-1] [Reference Citation Analysis]
2 Petrelli F, Ghidini M, Ghidini A, Sgroi G, Vavassori I, Petrò D, Cabiddu M, Aiolfi A, Bonitta G, Zaniboni A, Rausa E. Red blood cell transfusions and the survival in patients with cancer undergoing curative surgery: a systematic review and meta-analysis. Surg Today 2021. [PMID: 33389174 DOI: 10.1007/s00595-020-02192-3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
3 Ito T, Kuriyama N, Kozuka Y, Komatsubara H, Ichikawa K, Noguchi D, Hayasaki A, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S. High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection. BMC Cancer 2020;20:209. [PMID: 32164621 DOI: 10.1186/s12885-020-6695-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
4 Ito K, Sakamoto Y, Isayama H, Nakai Y, Watadani T, Tanaka M, Ushiku T, Akamatsu N, Kaneko J, Arita J, Hasegawa K, Kokudo N. The Impact of MDCT and Endoscopic Transpapillary Mapping Biopsy to Predict Longitudinal Spread of Extrahepatic Cholangiocarcinoma. J Gastrointest Surg 2018;22:1528-37. [DOI: 10.1007/s11605-018-3793-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
5 Courtin-tanguy L, Turrini O, Bergeat D, Truant S, Darnis B, Delpero JR, Mabrut JY, Regenet N, Sulpice L. Multicentre study of the impact of factors that may affect long-term survival following pancreaticoduodenectomy for distal cholangiocarcinoma. HPB 2018;20:405-10. [DOI: 10.1016/j.hpb.2017.10.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kim BH, Chie EK, Kim K, Jang JY, Kim SW, Oh DY, Bang YJ, Ha SW. Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution. Oncotarget 2017;8:78076-85. [PMID: 29100449 DOI: 10.18632/oncotarget.17368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
7 Kim BH, Kim K, Chie EK, Kwon J, Jang JY, Kim SW, Oh DY, Bang YJ. Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution. Cancer Res Treat 2017;49:473-83. [PMID: 27554480 DOI: 10.4143/crt.2016.166] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
8 Kato Y, Takahashi S, Gotohda N, Konishi M. The Likely Sites of Nodal Metastasis Differs According to the Tumor Extent in Distal Bile Duct Cancer. J Gastrointest Surg 2016;20:1618-27. [PMID: 27255658 DOI: 10.1007/s11605-016-3179-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Ahn KS, Kang KJ, Kang YN, Kim YH, Kim TS. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma. BMC Gastroenterol 2016;16:21. [PMID: 26911927 DOI: 10.1186/s12876-016-0444-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
10 Mavros MN, Xu L, Maqsood H, Gani F, Ejaz A, Spolverato G, Al-Refaie WB, Frank SM, Pawlik TM. Perioperative Blood Transfusion and the Prognosis of Pancreatic Cancer Surgery: Systematic Review and Meta-analysis. Ann Surg Oncol. 2015;22:4382-4391. [PMID: 26293837 DOI: 10.1245/s10434-015-4823-6] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 9.6] [Reference Citation Analysis]
11 Yan PZ, Zhao LJ, Tu K, Wang F. Curative effect of surgical treatment of hilar cholangiocarcinoma: Analysis of 41 cases. Shijie Huaren Xiaohua Zazhi 2015; 23(16): 2614-2618 [DOI: 10.11569/wcjd.v23.i16.2614] [Reference Citation Analysis]
12 Strongin A, Singh H, Eloubeidi MA, Siddiqui AA. Role of endoscopic ultrasonography in the evaluation of extrahepatic cholangiocarcinoma. Endosc Ultrasound 2013;2:71-6. [PMID: 24949368 DOI: 10.4103/2303-9027.117690] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
13 Strongin A, Singh H, Eloubeidi MA, Siddiqui AA. Role of endoscopic ultrasonography in the evaluation of extrahepatic cholangiocarcinoma. Endosc Ultrasound. 2013;2:71-76. [PMID: 24949368 DOI: 10.7178/eus.05.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Goto T, Ajiki T, Murakami S, Matsumoto I, Shinzeki M, Asari S, Mukubou H, Okazaki T, Kido M, Fukumoto T, Ku Y. Rapid progression of second bile duct cancer after resection for extrahepatic bile duct cancer. Int Canc Conf J 2014;3:173-7. [DOI: 10.1007/s13691-013-0141-7] [Reference Citation Analysis]
15 Han IW, Jang JY, Lee KB, Kang MJ, Kwon W, Park JW, Chang YR, Kim SW. Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin. HPB (Oxford) 2014;16:575-81. [PMID: 24308425 DOI: 10.1111/hpb.12193] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
16 DeOliveira ML, Kambakamba P, Clavien PA. Advances in liver surgery for cholangiocarcinoma. Curr Opin Gastroenterol. 2013;29:293-298. [PMID: 23563982 DOI: 10.1097/mog.0b013e3283600a92] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
17 Sano T, Shimizu Y, Senda Y, Komori K, Ito S, Abe T, Kinoshita T, Nimura Y. Isolated caudate lobectomy with pancreatoduodenectomy for a bile duct cancer. Langenbecks Arch Surg 2013;398:1145-50. [PMID: 24026222 DOI: 10.1007/s00423-013-1110-5] [Reference Citation Analysis]
18 La Gamma N, Nandakumar G. The management of gastrointestinal tract malignancies. Hosp Pract (1995) 2013;41:7-15. [PMID: 23545755 DOI: 10.3810/hp.2013.04.1021] [Reference Citation Analysis]
19 Sakamoto Y, Nara S, Kishi Y, Esaki M, Shimada K, Kokudo N, Kosuge T. Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer? Surgery. 2013;153:794-800. [PMID: 23415082 DOI: 10.1016/j.surg.2012.11.024] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 4.8] [Reference Citation Analysis]
20 Turaga KK, Tsai S, Wiebe LA, Evans DB, Gamblin TC. Novel multimodality treatment sequencing for extrahepatic (mid and distal) cholangiocarcinoma. Ann Surg Oncol 2013;20:1230-9. [PMID: 23064778 DOI: 10.1245/s10434-012-2648-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, Nagino M. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg. 2012;256:297-305. [PMID: 22750757 DOI: 10.1097/sla.0b013e31826029ca] [Cited by in Crossref: 129] [Cited by in F6Publishing: 125] [Article Influence: 12.9] [Reference Citation Analysis]
22 Yu H, Wu SD, Tian Y, Su Y, Li YN. Single-incision laparoscopic resection of Bismuth I hilar cholangiocarcinoma. Surg Innov 2013;20:209-13. [PMID: 22393076 DOI: 10.1177/1553350612438414] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
23 Boland B, Kim A, Nissen N, Colquhoun S. Cholangiocarcinoma: Aggressive Surgical Intervention Remains Justified. The American Surgeon 2012;78:157-60. [DOI: 10.1177/000313481207800231] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
24 Song SC, Heo JS, Choi DW, Choi SH, Kim WS, Kim MJ. Survival benefits of surgical resection in recurrent cholangiocarcinoma. J Korean Surg Soc 2011;81:187-94. [PMID: 22066120 DOI: 10.4174/jkss.2011.81.3.187] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
25 Kaneoka Y, Yamaguchi A, Isogai M, Kumada T. Survival benefit of hepatopancreatoduodenectomy for cholangiocarcinoma in comparison to hepatectomy or pancreatoduodenectomy. World J Surg. 2010;34:2662-2670. [PMID: 20607255 DOI: 10.1007/s00268-010-0702-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
26 Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol 2011; 2(2): 94-107 [PMID: 21603318 DOI: 10.5306/wjco.v2.i2.94] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]